期刊
JOURNAL OF MOVEMENT DISORDERS
卷 9, 期 1, 页码 14-19出版社
KOREAN MOVEMENT DISORDERS SOC
DOI: 10.14802/jmd.15059
关键词
Synucleinopathy; alpha-synuclein; Aggregate transmission; Microglia activation; Immunotherapy
资金
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Ministry of Health & Welfare, Republic of Korea [HI14C0093]
Immunization therapy targeting alpha-synuclein has emerged as a promising approach for Parkinson's disease and perhaps for other synucleinopathies. Several antibodies have shown therapeutic effects in mouse models of synucleinopathies and have alleviated the pathological and behavioral phenotypes of these mice. The mechanisms through which the immunization therapy works were initially puzzling, especially given that alpha-synuclein is a typical cytosolic protein. Recent studies, however, suggested that extracellular alpha-synuclein is an important pathogenic entity, and hence, a target for immunotherapy. Here, we review the literature describing immunization therapy for synucleinopathies in mouse models and provide current thoughts on the potential mechanisms underlying the therapeutic effects of alpha-synuclein immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据